Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12F. Hoffmann-La Roche

02 4Genentech

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra

Dosage Form : Inj L?s

Dosage Strength : 105mg/0.7ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra

Dosage Form : Inj Solution

Dosage Strength : 150mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra

Dosage Form : Inj Solution

Dosage Strength : 30mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra

Dosage Form : Inj Loose

Dosage Strength : 60mg/0.4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 30MG/1ML

Packaging : 1ML

Approval Date :

Application Number : 2479621

Regulatory Info : Prescription

Registration Country : Canada

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 60MG/0.4ML

Packaging : 0.4ML

Approval Date :

Application Number : 2479648

Regulatory Info : Prescription

Registration Country : Canada

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 105MG/0.7ML

Packaging : 0.7ML

Approval Date :

Application Number : 2479656

Regulatory Info : Prescription

Registration Country : Canada

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 150MG/ML

Packaging :

Approval Date :

Application Number : 2479664

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 105mg/0.7 ml

Dosage Form : INJ

Dosage Strength : 105mg

Packaging : 0.7X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 150mg/1 ml

Dosage Form : INJ

Dosage Strength : 150mg

Packaging : 1X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 60mg/0.4 ml

Dosage Form : INJ

Dosage Strength : 60mg

Packaging : 0.4X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 30mg/1 ml

Dosage Form : INJ

Dosage Strength : 30mg

Packaging : 1X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 30MG/ML

Packaging :

Approval Date :

Application Number : 761083

Regulatory Info :

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 60MG/0.4ML

Packaging :

Approval Date :

Application Number : 761083

Regulatory Info :

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 105MG/0.7ML

Packaging :

Approval Date :

Application Number : 761083

Regulatory Info :

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 761083

Regulatory Info :

Registration Country : USA

blank